切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 324 -326. doi: 10.3877/cma.j.issn.1674-0807.2021.05.011

病例报告

原发性乳腺淋巴瘤一例及文献复习
易顺1, 谭米多1, 周围1,()   
  1. 1. 412007 湖南 株洲,中南大学湘雅医学院附属株洲医院乳腺外科
  • 收稿日期:2019-10-06 出版日期:2021-10-01
  • 通信作者: 周围

Primary breast lymphoma: one case report and literature review

Shun Yi1, Miduo Tan1, Wei Zhou1()   

  • Received:2019-10-06 Published:2021-10-01
  • Corresponding author: Wei Zhou
引用本文:

易顺, 谭米多, 周围. 原发性乳腺淋巴瘤一例及文献复习[J/OL]. 中华乳腺病杂志(电子版), 2021, 15(05): 324-326.

Shun Yi, Miduo Tan, Wei Zhou. Primary breast lymphoma: one case report and literature review[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2021, 15(05): 324-326.

图1 原发性乳腺淋巴瘤彩色超声图 a图所示肿块声像图;b图所示分隔上血流信号(见红圈处);c图所示分隔上测及高阻力动脉频谱
图2 原发性乳腺淋巴瘤X线摄影图  a、b图分别所示头尾位和内外斜位X线摄影图
图3 原发性乳腺淋巴瘤病理表现(HE ×100)  a、b图分别所示乳腺不同区域的原发性淋巴瘤
[1]
Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the international extranodal lymphoma study group [J]. Ann Oncol, 2008, 19(2): 233-241.
[2]
Thomas A, Link BK, Altekruse S, et al. Primary breast lymphoma in the united states: 1975-2013 [J]. J Natl Cancer Inst, 2017, 109(6): djw294.
[3]
Aviles A, Delgado S, Nambo MJ, et al. Primary breast lymphoma: results of a controlled clinical trial [J]. Oncology, 2005, 69(3): 256-260.
[4]
Zhao YF, Jiao F, Liang HQ, et al. Primary malignant non-hodgkin’s lymphoma of the breast: a case report [J]. Oncol Lett, 2014, 8(6): 2597-2600.
[5]
Aviv A, Tadmor T, Polliack A. Primary diffuse large b-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options [J]. Ann Oncol, 2013, 24(9): 2236-2244.
[6]
Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma [J]. Cancer Treat Rev, 2014, 40(8): 900-908.
[7]
Hosein PJ, Maragulia JC, Salzberg MP, et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era [J]. Br J Haematol, 2014, 165(3): 358-363.
[8]
Nichter LS, Mueller MA, Burns RG, et al. First report of nodal marginal zone B-cell lymphoma associated with breast implants [J]. Plast Reconstr Surg, 2012, 129(3): 576e-578e.
[9]
Rupani A, Frame JD, Kamel D. Lymphomas associated with breast implants: a review of the literature [J]. Aesthet Surg J, 2015, 35(5): 533-544.
[10]
De Jong D, Vasmel WL, De Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants [J]. JAMA, 2008, 300(17): 2030-2035.
[11]
Miranda RN, Aladily TN, Prince HM, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients [J]. J Clin Oncol, 2014, 32(2): 114-120.
[12]
Avenia N, Sanguinetti A, Cirocchi R, et al. Primary breast lymphomas: a multicentric experience [J]. World J Surg Oncol, 2010, 8:53.
[13]
Jung SP, Kim M, Han KM, et al. Primary breast lymphoma: a single institution’s experience [J]. J Korean Surg Soc, 2013, 84(5): 267-272.
[14]
Inic Z, Inic M, Zegarac M, et al. Three cases of combined therapy in primary breast lymphoma (pbl) with successful outcomes [J]. Clin Med Insights Oncol, 2013, 7:159-163.
[15]
Domchek SM, Hecht JL, Fleming MD, et al. Lymphomas of the breast: primary and secondary involvement [J]. Cancer, 2002, 94(1): 6-13.
[16]
Jabbour G, El-Mabrok G, Al-Thani H, et al. Primary breast lymphoma in a woman: a case report and review of the literature [J]. Am J Case Rep, 2016, 17:97-103.
[17]
Surov A, Holzhausen HJ, Wienke A, et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features [J]. Br J Radiol, 2012, 85(1014): e195-205.
[18]
Wiseman C, Liao KT. Primary lymphoma of the breast [J]. Cancer, 1972, 29(6): 1705-1712.
[19]
Jeanneret-Sozzi W, Taghian A, Epelbaum R, et al. Primary breast lymphoma: patient profile, outcome and prognostic factors. a multicentre rare cancer network study [J]. BMC Cancer, 2008, 8:86.
[20]
Jennings WC, Baker RS, Murray SS, et al. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status [J]. Ann Surg, 2007, 245(5): 784-789.
[21]
Caon J, Wai ES, Hart J, et al. Treatment and outcomes of primary breast lymphoma [J]. Clin Breast Cancer, 2012, 12(6): 412-419.
[22]
Martelli M, Ferreri AJ, Agostinelli C, et al. Diffuse large B-cell lymphoma [J]. Crit Rev Oncol Hematol, 2013, 87(2): 146-171.
[23]
Yhim HY, Kang HJ, Choi YH, et al. Clinical outcomes and prognostic factors in patients with breast diffuse large b cell lymphoma; consortium for improving survival of lymphoma (CISL) study [J]. BMC Cancer, 2010, 10:321.
[24]
Wadhwa A, Senebouttarath K. Primary lymphoma of the breast: a case series [J]. Radiol Case Rep, 2018, 13(4): 815-821.
[25]
Coiffier B, Lepage E, Briere J, et al. Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma [J]. New Engl J Med, 2002, 346(4): 235-242.
[26]
Shao YB, Sun XF, He YN, et al. Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature [J]. Med Oncol, 2015, 32(2): 448.
[27]
Millis RR, Bobrow LG, Rubens RD, et al. Histiocytic lymphoma of breast responds to tamoxifen [j]. Br J Cancer, 1988, 58(6): 808-809.
[28]
Scariano JK, Emery-Cohen AJ, Pickett GG, et al. Estrogen receptors alpha (esr1) and beta (esr2) are expressed in circulating human lymphocytes [J]. J Recept Signal Transduct Res, 2008, 28(3): 285-293.
[29]
Shim GJ, Gherman D, Kim HJ, et al. Differential expression of oestrogen receptors in human secondary lymphoid tissues [J]. J Pathol, 2006, 208(3): 408-414.
[1] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 费翔, 马帅, 张颖, 高洋, 毕冬宁, 孙平东, 崔建春. 乳腺腺叶可视化技术在乳管内乳头状瘤手术中的应用[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 464-464.
[9] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[10] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[11] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?